SK

Subhash Kumar

Active Director Director DIN 08422893
DIN 08422893 First appointment May 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Subhash Kumar

Data last updated:

Subhash Kumar is a Director at Clarshen Pharmaceuticals Private Limited (since 2024). The company operates in Chemicals. Clarshen Pharmaceuticals Private Limited reported revenue of ₹27 Lakh (FY 2025).

DIN 08422893
Primary Designation Director
Industry Chemicals
First Appointment 10 May 2024
Oldest Company Age 7 yrs
Largest company Clarshen Pharmaceuticals Private Limited · ₹27 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20242019₹27 Lakh (FY 2025)Active

Board colleagues of Subhash Kumar

NameDINCompanyDesignation
Bhavana08813964Clarshen Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clarshen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subhash Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhash Kumar

Subhash Kumar currently holds 1 directorship: Clarshen Pharmaceuticals Private Limited (Director, since 10 May 2024, revenue ₹27 Lakh (FY 2025)).

Subhash Kumar was first appointed on 10 May 2024 as Director at Clarshen Pharmaceuticals Private Limited.

The current boards of Subhash Kumar's companies include Bhavana (Clarshen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available